UK's Oxford Nanopore shares dip after unchanged outlook disappoints

Oxford Nanopore Technologies

02/09/2025 14:45

** Shares of biotech firm Oxford Nanopore Technologies ONT.L down 9.3% at 168.05p

** Co keeps full-year guidance unchanged, despite expectations of an upgrade

** An analyst at Peel Hunt says, "Some investors had missed that there was some pull forward of revenues from a new ‘capex first’ pricing model"

** Analyst adds, it’s reasonable to expect that this ‘sugar rush’ of revenue might diminish over time, which could, in turn, have an impact on future sales of flow cell products and other consumables

** ONT moved from a “lease” model, where machines were free with a flow cell purchase commitment, to a “capex first” model requiring upfront payment for equipment

** ONT posts HY revenue 105.6 mln pounds ($142.66 mln), up 28% on a constant currency basis, led by growth in Asia and Europe

** Including session gains, stock up ~43% YTD

($1 = 0.7402 pounds)

 (Reporting by Ankita Bora in Bengaluru)

 ((Ankita.Bora@thomsonreuters.com))